IL3 and neoplasm: For example, in a mouse model, imatinib-laden IL3-exosomes significantly reduced the tumor burden when compared to imatinib-free IL3-exosomes, regular exosomes loaded with imatinib, and imatinib alone (p <0.0005) (81).